Parameter PR Group (n=12) SR Group (n=11) P value
Mean Median Mean Median
G (K dynes/cm2) 12.2 ± 5.90 10.9 [9.7, 15.1] 11.9 ± 3.73 13.4 [9.8, 14.4] 0.94
TEG® MA (mm) 71.9 ± 5.66 72.1 [67.5, 75] 68.7 ± 7.88 70.5 [66.3, 73.9] 0.60
MA Activator (mm) 9.4 ± 4.15 9.5 [8.1, 9.8] 9.9 ± 8.95 7.9 [4.9, 9.9] 0.47
ADP MA (mm) 51.7 ± 15.58 54.3 [43.1, 65.1] 55.1 ± 9.20 54.9 [51.1, 61.2] 0.86
AA MA (mm) 57.7 ± 19.28 64.1 [52.8, 68.4] 57.1 ± 16.32 63.7 [50.7, 67.8] 0.81
ADP Inhibition (%) 29.7 ± 21.81 24.8 [14.4, 43.9] 22.1 ± 15.09 20.5 [13.4, 30.4] 0.39
AA Inhibition (%) 24.3 ± 25.98 18.1 [11.2, 27.9] 19.5 ± 23.19 9.7 [5.0, 29.7] 0.56
ADP Aggregation (%) 0.7 ± 0.22 0.8 [0.6, 0.9] 0.8 ± 0.16 0.8 [0.7, 0.9] 0.45
AA Aggregation (%) 0.8 ± 0.26 0.8 [0.7, 0.9] 0.8 ± 0.23 0.9 [0.7, 1.0] 0.57
Data are presented as mean ± SD and median [1st Quartile, 3rd Quartile]. Two-tailed P value determined using Mann-Whitney U test. There were no statistically significant differences between the two groups. SD = Standard Deviation; PR = propofol/ remifentanyl; SR = sevoflurane/remifentanyl.
Table 3b: Postoperative TEG® PM™ Data.